161 related articles for article (PubMed ID: 22022477)
1. Hepatocyte IKK2 protects Mdr2-/- mice from chronic liver failure.
Ehlken H; Kondylis V; Heinrichsdorff J; Ochoa-Callejero L; Roskams T; Pasparakis M
PLoS One; 2011; 6(10):e25942. PubMed ID: 22022477
[TBL] [Abstract][Full Text] [Related]
2. Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in
Wang R; Sheps JA; Liu L; Han J; Chen PSK; Lamontagne J; Wilson PD; Welch I; Borchers CH; Ling V
J Lipid Res; 2019 Jan; 60(1):85-97. PubMed ID: 30416103
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosis.
Stiedl P; McMahon R; Blaas L; Stanek V; Svinka J; Grabner B; Zollner G; Kessler SM; Claudel T; Müller M; Mikulits W; Bilban M; Esterbauer H; Eferl R; Haybaeck J; Trauner M; Casanova E
Hepatology; 2015 Feb; 61(2):613-26. PubMed ID: 25179284
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB functions as a tumour promoter in inflammation-associated cancer.
Pikarsky E; Porat RM; Stein I; Abramovitch R; Amit S; Kasem S; Gutkovich-Pyest E; Urieli-Shoval S; Galun E; Ben-Neriah Y
Nature; 2004 Sep; 431(7007):461-6. PubMed ID: 15329734
[TBL] [Abstract][Full Text] [Related]
5. Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice.
Baghdasaryan A; Fickert P; Fuchsbichler A; Silbert D; Gumhold J; Hörl G; Langner C; Moustafa T; Halilbasic E; Claudel T; Trauner M
Liver Int; 2008 Aug; 28(7):948-58. PubMed ID: 18410282
[TBL] [Abstract][Full Text] [Related]
6. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
[TBL] [Abstract][Full Text] [Related]
7. Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2
Fuchs CD; Dixon ED; Hendrikx T; Mlitz V; Wahlström A; Ståhlman M; Scharnagl H; Stojakovic T; Binder CJ; Marschall HU; Trauner M
Hepatol Commun; 2022 Sep; 6(9):2368-2378. PubMed ID: 35691019
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress.
Tebbi A; Levillayer F; Jouvion G; Fiette L; Soubigou G; Varet H; Boudjadja N; Cairo S; Hashimoto K; Suzuki AM; Carninci P; Carissimo A; di Bernardo D; Wei Y
Carcinogenesis; 2016 Jan; 37(1):39-48. PubMed ID: 26542370
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
[TBL] [Abstract][Full Text] [Related]
10. Moderate activation of IKK2-NF-kB in unstressed adult mouse liver induces cytoprotective genes and lipogenesis without apparent signs of inflammation or fibrosis.
Lu H; Lei X; Zhang Q
BMC Gastroenterol; 2015 Jul; 15():94. PubMed ID: 26219821
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis.
Svinka J; Pflügler S; Mair M; Marschall HU; Hengstler JG; Stiedl P; Poli V; Casanova E; Timelthaler G; Sibilia M; Eferl R
J Mol Med (Berl); 2017 Jan; 95(1):109-117. PubMed ID: 27568040
[TBL] [Abstract][Full Text] [Related]
13. The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.
Gamaev L; Mizrahi L; Friehmann T; Rosenberg N; Pappo O; Olam D; Zeira E; Bahar Halpern K; Caruso S; Zucman-Rossi J; Axelrod JH; Galun E; Goldenberg DS
Oncogene; 2021 Jan; 40(1):127-139. PubMed ID: 33093654
[TBL] [Abstract][Full Text] [Related]
14. Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.
Potikha T; Pappo O; Mizrahi L; Olam D; Maller SM; Rabinovich GA; Galun E; Goldenberg DS
FASEB J; 2019 Jul; 33(7):7995-8007. PubMed ID: 30897344
[TBL] [Abstract][Full Text] [Related]
15. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury.
Luedde T; Assmus U; Wüstefeld T; Meyer zu Vilsendorf A; Roskams T; Schmidt-Supprian M; Rajewsky K; Brenner DA; Manns MP; Pasparakis M; Trautwein C
J Clin Invest; 2005 Apr; 115(4):849-59. PubMed ID: 15776110
[TBL] [Abstract][Full Text] [Related]
16. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Deficiency Promotes the Ductular Reaction, Macrophage Accumulation, and Hepatic Fibrosis in the Abcb4
Krishnan A; Katsumi T; Guicciardi ME; Azad AI; Ozturk NB; Trussoni CE; Gores GJ
Am J Pathol; 2020 Jun; 190(6):1284-1297. PubMed ID: 32240619
[TBL] [Abstract][Full Text] [Related]
17. B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury.
Faggioli F; Palagano E; Di Tommaso L; Donadon M; Marrella V; Recordati C; Mantero S; Villa A; Vezzoni P; Cassani B
Hepatology; 2018 May; 67(5):1970-1985. PubMed ID: 29105104
[TBL] [Abstract][Full Text] [Related]
18. NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.
Kondylis V; Polykratis A; Ehlken H; Ochoa-Callejero L; Straub BK; Krishna-Subramanian S; Van TM; Curth HM; Heise N; Weih F; Klein U; Schirmacher P; Kelliher M; Pasparakis M
Cancer Cell; 2015 Nov; 28(5):582-598. PubMed ID: 26555174
[TBL] [Abstract][Full Text] [Related]
19. Wnt/β-Catenin Signaling Plays a Protective Role in the Mdr2 Knockout Murine Model of Cholestatic Liver Disease.
Pradhan-Sundd T; Kosar K; Saggi H; Zhang R; Vats R; Cornuet P; Green S; Singh S; Zeng G; Sundd P; Nejak-Bowen K
Hepatology; 2020 May; 71(5):1732-1749. PubMed ID: 31489648
[TBL] [Abstract][Full Text] [Related]
20. Knockout of the Tachykinin Receptor 1 in the Mdr2
Ceci L; Francis H; Zhou T; Giang T; Yang Z; Meng F; Wu N; Kennedy L; Kyritsi K; Meadows V; Wu C; Liangpunsakul S; Franchitto A; Sybenga A; Ekser B; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
Am J Pathol; 2020 Nov; 190(11):2251-2266. PubMed ID: 32712019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
